In addition, age, BMI, NRS-2002 score, CEA level, pathological T stage, pathological N stage, tumor differentiation, vascular invasion, adjuvant therapy, white blood cell count, albumin and hemoglobin levels were significant predictors of DFS (Supplementary Table 3). This evidence concerns the gene CEACAM5 and neoplasm.